A mouse model with humanized telomere homeostasis

NIH RePORTER · NIH · R56 · $313,650 · view on reporter.nih.gov ↗

Abstract

Abstract The goal of this project is to develop a mouse model that acquires human-like telomere homeostasis for the study of human aging, cancer, and other age-related diseases. In humans, most somatic cells lack telomerase expression and cannot replenish their telomeres. Consequently, telomeres progressively shortened upon successive cell divisions and function as an aging clock. Accordingly, telomere shortening is a critical factor of human aging and telomerase activation is essential for the development of most human cancers. On the other hand, some other organisms, including laboratory mice, do not exhibit telomere-mediated replicative aging. Mice possess long telomeres and ubiquitous telomerase activity in adult tissues. This interspecies difference has become a bottleneck for addressing many fundamental questions in human aging and cancer biology using mouse models. To tackle this challenge, we have started to create a mouse strain with humanized telomere homeostasis. Here, we have engineered a humanized mouse Tert allele (hmTert) by using regulatory sequences from the human TERT gene (hTERT) to replace their mouse counterparts. We found that the hmTert gene regulation recapitulated that of the hTERT gene during mouse development and in mouse adult tissues. In this application, we propose the following three specific aims: 1) Create a mouse strain with hmTert alleles and human-like short telomeres; 2) Study replicative aging in mice with humanized telomere homeostasis; and 3) Determine lifespan and health-span of mice with humanized telomere homeostasis.

Key facts

NIH application ID
10490487
Project number
1R56AG073423-01
Recipient
WASHINGTON STATE UNIVERSITY
Principal Investigator
JIYUE ZHU
Activity code
R56
Funding institute
NIH
Fiscal year
2021
Award amount
$313,650
Award type
1
Project period
2021-09-30 → 2022-08-31